Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

What do the Fidelity ZERO mutual funds mean for physician investors?

Wall Street Physician, MD
Finance
August 20, 2018
Share
Tweet
Share

Vanguard, Fidelity, and Schwab have been engaging in a fierce competition to claim the mantle as the leading provider of low-cost index funds. As a result, each has aggressively lowered their fees for their index fund offerings over the past few years and advertised their low-cost offerings to investors.

After the latest round of fee reductions in mid-2017, I wrote a post speculating whether it was inevitable that Vanguard, Fidelity, or Schwab would offer a zero expense ratio mutual fund.

That’s right, an index fund that charges no management fee to its investors.

On August 3, 2018, Fidelity made the zero expense ratio index fund a reality, when they began offering the Fidelity ZERO Total Market Index Fund (FZROX), and the Fidelity ZERO International Index Fund (FZILX) to investors.

FZROX gives investors exposure to the total U.S. stock market (through the Fidelity U.S. Total Investable Market Index), while the FZILX tracks a global international stock index (the Fidelity Global ex U.S. Index).

These two funds will allow Fidelity investors to have exposure to the global stock market with zero fees.

Fidelity announced more than just two 0.00% expense ratio index funds

The announcement of zero expense ratio mutual funds was part of a broader reduction in fees by Fidelity.

Lower fees nearly across the board for Fidelity index funds

For three-fund portfolio investors at Fidelity, the Fidelity Total Stock Market Index Fund now has a 0.015% expense ratio (previously 0.035%). The Fidelity U.S. Bond Index Fund (FSITX) now has an expense ratio of 0.025% (previously 0.045%). The Fidelity Total International Index Fund (FTIPX) now has an expense ratio of 0.06% (previously 0.10%).

No minimum investment for Fidelity index funds

If that wasn’t enough good news for Fidelity investors, Fidelity also stopped having minimum investments in order to get the lowest expense ratios. Previously, retail investors had to invest a minimum of $10,000 in a single fund in order to access the lower cost Premium shares, while those who wanted to invest less than $10,000 in an index mutual fund would have had to use the higher-cost Investor shares, which still had a $3,000 minimum. Now, there is no minimum investment for Fidelity’s index funds, and all share classes have the same expense ratio. Previously, Schwab was the only major index fund provider that had no minimum investment for their index mutual funds.

Wider range of commission-free ETFs

ADVERTISEMENT

Vanguard made news in June 2018 when they announced that they would offer over 1,800 ETF’s commission free, including funds from major index ETF providers such as iShares.

Fidelity, as part of their changes, expanded their set of commission-free ETFs to 265 ETFs(iShares and Fidelity) – previously they had fewer than 100 commission-free ETFs. With these ETFs, you can build almost any index portfolio commission-free.

Summary of Fidelity fee changes

To summarize, here are the changes Fidelity made in August 2018 to their fee structure:

  1. Introduction of two zero expense ratio index funds, FZROX and FZILX.
  2. Nearly across-the-board reductions in their existing index fund expense ratios.
  3. Elimination of investment minimums to buy their lowest expense ratio index funds.
  4. Expansion of the number of Fidelity and iShares commission-free ETFs.

What do these changes mean for you?

All index investors will be affected, directly or indirectly, from these Fidelity announcements.

Existing Vanguard and Schwab investors should not switch

I would not recommend existing Vanguard and Schwab investors to move their money to Fidelity to buy the Fidelity ZERO index funds.

The difference between paying 0.00% for Fidelity ZERO index funds and paying 0.03-0.07% at Vanguard or Schwab will not be the difference between a good and a great retirement. In fact, if you liquidate your Vanguard or Schwab index funds from a taxable account, you will hurt yourself by creating capital gains taxes.

Fidelity may be the first company to offer zero expense ratio index funds, but I doubt they will be the last. I expect Vanguard and Schwab to offer their own zero expense ratio index fund in the coming years, especially if the Fidelity ZERO index funds gain traction (which I expect they will).

Fidelity may be the first company to offer zero expense ratio index funds, but I doubt they will be the last.

Even Fidelity investors should not buy FZROX or FZILX in taxable accounts

Even Fidelity investors should not sell investments in their taxable accounts to buy the Fidelity ZERO index funds. As with Vanguard and Schwab, selling shares in a taxable account would incur capital gains taxes. These taxes blunt the compounding power of your investments, which would overwhelm the tiny expense ratio benefit from the new Fidelity ZERO funds.

I would also argue that you should not put new money into these index funds within a taxable account. Mutual funds are slightly tax-inefficient compared to ETFs, because mutual funds have to distribute capital gains, which are taxable, while ETFs do not. This erosion in after-tax returns is likely greater than the difference in expense ratios between the Fidelity ZERO index funds and commission-free iShares ETFs, such as ITOT or IEFA.

Fidelity investors should consider choosing the Fidelity ZERO mutual funds in retirement accounts

In retirement accounts such as a Roth IRA, you can certainly exchange your current index funds for FZROX or FZILX funds, since selling shares within a retirement account do not incur capital gains taxes.

However, it is important to keep perspective that you would save only $15 per $100,000 invested per year in FZROX over FSTVX and $60 per $100,000 invested per year in FZILX over FTIPX or FSGDX.

The Fidelity ZERO index funds track unique indices

Fidelity has created new reference indices for their new Fidelity ZERO mutual funds.

FZROX tracks the Fidelity U.S. Total Investable Market Index, while FZILX tracks the Fidelity Global ex U.S. Index.

I am not concerned about tracking error with the use of internal reference indices, because these indices are publicly available and the reference index return can be tracked by third parties. Both the Fidelity U.S. Total Investable Market Index (used by FZROX) and the Fidelity Global Ex US Index can be tracked on the S&P Dow Jones website, and I don’t anticipate that their tracking error will be significantly different from FSTVX and FTIPX.

Fidelity will gain market share in the short run, especially among new investors

There is something magical about the word free. Even though it was a cut of only a few basis points, Fidelity’s ability to claim a zero expense ratio mutual fund will stick in investor’s minds far more than previous expense ratio cuts in their funds.

I fully expect that this change will help Fidelity gain more market share than Vanguard’s addition of commission-free ETFs. If this happens, expect Vanguard and Schwab to offer their own zero expense ratiio index funds to compete.

Where do expense ratios go from here?

There is speculation on the internet that with zero expense ratio index funds now being offered to investors, a negative expense ratio index fund could be on the horizon. In this scenario, fund companies would actually pay investors to invest in their index funds.

I’m not sure this is the next step in the fee wars. If the Fidelity ZERO index funds succeed, I expect Fidelity to expand their ZERO index fund series to additional asset classes.

At some point, investors will realize that you can get zero or near-zero expense ratio index funds at Vanguard, Fidelity, or Schwab. These companies will need to work on other things like offering even better customer service or improving their website and app interfaces to gain market share.

Conclusion

Investors should welcome the introduction of two zero expense ratio index funds by Fidelity, even if they do not personally invest in them. It is a sign that Vanguard, Fidelity, and Schwab are continuing to undercut each other’s fees in order to attract your investment dollars.

Other than within a Fidelity retirement account, I would not advise selling any current investments to buy these funds. Fidelity investors can consider investing new money into these two new index funds within a retirement account.

“Wall Street Physician,” a former Wall Street derivatives trader , is a physician who blogs at his self-titled site, the Wall Street Physician.

Image credit: Shutterstock.com

Prev

MKSAP: 30-year-old woman with HIV infection

August 20, 2018 Kevin 0
…
Next

This infectious disease physician still finds HIV care rewarding. Here's why.

August 20, 2018 Kevin 0
…

Tagged as: Practice Management

Post navigation

< Previous Post
MKSAP: 30-year-old woman with HIV infection
Next Post >
This infectious disease physician still finds HIV care rewarding. Here's why.

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

More by Wall Street Physician, MD

  • 4 reasons why physicians should hire a financial advisor

    Wall Street Physician, MD
  • Investing in the stock market is like playing that game of rock-paper-scissors

    Wall Street Physician, MD
  • 7 sources of financial anxiety for physicians

    Wall Street Physician, MD

Related Posts

  • A physician’s addiction to social media

    Amanda Xi, MD
  • How a physician keynote can highlight your conference

    Kevin Pho, MD
  • Chasing numbers contributes to physician burnout

    DrizzleMD
  • The black physician’s burden

    Naomi Tweyo Nkinsi
  • Why this physician supports Medicare for all

    Thad Salmon, MD
  • Embrace the teamwork involved in becoming a physician

    Nathaniel Fleming

More in Finance

  • The hidden impact of denials on health care systems

    Diana Ortiz, JD
  • Why physicians are unlike the “average” investor

    David B. Mandell, JD, MBA
  • Signing bonuses and taxes: What physicians should know

    Shane Tenny, CFP
  • 5 steps to ride out a non-compete without uprooting your family

    Stanley Liu, MD
  • What every physician should know before buying into a medical practice

    Dennis Hursh, Esq
  • Navigating your 457 plan: key steps for physicians changing jobs

    Shane Tenny, CFP
  • Most Popular

  • Past Week

    • The broken health care system doesn’t have to break you

      Jessie Mahoney, MD | Physician
    • How scales of justice saved a doctor-patient relationship

      Neil Baum, MD | Physician
    • How dismantling DEI endangers the future of medical care

      Shashank Madhu and Christian Tallo | Education
    • Why shared decision-making in medicine often fails

      M. Bennet Broner, PhD | Conditions
    • “Think twice, heal once”: Why medical decision-making needs a second opinion from your slower brain (and AI)

      Harvey Castro, MD, MBA | Tech
    • Do Jewish students face rising bias in holistic admissions?

      Anonymous | Education
  • Past 6 Months

    • What’s driving medical students away from primary care?

      ​​Vineeth Amba, MPH, Archita Goyal, and Wayne Altman, MD | Education
    • Internal Medicine 2025: inspiration at the annual meeting

      American College of Physicians | Physician
    • A faster path to becoming a doctor is possible—here’s how

      Ankit Jain | Education
    • Residency as rehearsal: the new pediatric hospitalist fellowship requirement scam

      Anonymous | Physician
    • Are quotas a solution to physician shortages?

      Jacob Murphy | Education
    • The hidden bias in how we treat chronic pain

      Richard A. Lawhern, PhD | Meds
  • Recent Posts

    • Love on life support: a powerful reminder from the ICU

      Syed Ahmad Moosa, MD | Physician
    • Surviving kidney disease and reforming patient care [PODCAST]

      The Podcast by KevinMD | Podcast
    • Why we fear being forgotten more than death itself

      Patrick Hudson, MD | Physician
    • My journey from misdiagnosis to living fully with APBD

      Jeff Cooper | Conditions
    • Antimicrobial resistance: a public health crisis that needs your voice [PODCAST]

      The Podcast by KevinMD | Podcast
    • Why a fourth year will not fix emergency medicine’s real problems

      Anna Heffron, MD, PhD & Polly Wiltz, DO | Education

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 1 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • The broken health care system doesn’t have to break you

      Jessie Mahoney, MD | Physician
    • How scales of justice saved a doctor-patient relationship

      Neil Baum, MD | Physician
    • How dismantling DEI endangers the future of medical care

      Shashank Madhu and Christian Tallo | Education
    • Why shared decision-making in medicine often fails

      M. Bennet Broner, PhD | Conditions
    • “Think twice, heal once”: Why medical decision-making needs a second opinion from your slower brain (and AI)

      Harvey Castro, MD, MBA | Tech
    • Do Jewish students face rising bias in holistic admissions?

      Anonymous | Education
  • Past 6 Months

    • What’s driving medical students away from primary care?

      ​​Vineeth Amba, MPH, Archita Goyal, and Wayne Altman, MD | Education
    • Internal Medicine 2025: inspiration at the annual meeting

      American College of Physicians | Physician
    • A faster path to becoming a doctor is possible—here’s how

      Ankit Jain | Education
    • Residency as rehearsal: the new pediatric hospitalist fellowship requirement scam

      Anonymous | Physician
    • Are quotas a solution to physician shortages?

      Jacob Murphy | Education
    • The hidden bias in how we treat chronic pain

      Richard A. Lawhern, PhD | Meds
  • Recent Posts

    • Love on life support: a powerful reminder from the ICU

      Syed Ahmad Moosa, MD | Physician
    • Surviving kidney disease and reforming patient care [PODCAST]

      The Podcast by KevinMD | Podcast
    • Why we fear being forgotten more than death itself

      Patrick Hudson, MD | Physician
    • My journey from misdiagnosis to living fully with APBD

      Jeff Cooper | Conditions
    • Antimicrobial resistance: a public health crisis that needs your voice [PODCAST]

      The Podcast by KevinMD | Podcast
    • Why a fourth year will not fix emergency medicine’s real problems

      Anna Heffron, MD, PhD & Polly Wiltz, DO | Education

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

What do the Fidelity ZERO mutual funds mean for physician investors?
1 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...